CORE--IMMUNOLOGY AND MOLECULAR BIOLOGY FACILITY
核心——免疫学和分子生物学设施
基本信息
- 批准号:6301198
- 负责人:
- 金额:$ 16.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This Core Laboratory will provide support in five areas: (1) to produce,
maintain, and characterize antibodies, (2) to analyze genomic DNA by
polymerase chain reaction, (3) to analyze and to quantitate cellular
mRNA, (4) to provide histopathology, immunohistochemistry, and in situ
hybridization support, and (5) to maintain bacterial culture and plasmid
stocks.
(1st Core Area). Western blots are used to characterize antibody
specificity and cross reactivity to pancreatic lipases, cholesterol
esterase, phospholipase A/2, and to lipid binding proteins though to be
involved in lipid uptake by the epithelial cells of the small intestine.
These antibodies are used in Western blots, enzyme linked immunosorbent
assays, and in immunohistochemical studies to measure changes in protein
amount and location that occur in tissues and fluids in response to
dietary manipulations, gene knock out, and ectopic expression of
pancreatic lipase.
(2nd Core Area). The progeny of targeted gene knock out mice are
genotyped by polymerase chain reaction. Genotyping of human DNA is
performed to assess apoE alleles and apoA-IV alleles in a population of
potential study patients.
(3rd Core Area). Cellular mRNA for human low density lipoprotein
receptor and for hydroxymethylglutaryl CoA reductase is characterized by
reverse transcription polymerase chain reaction. The changes in mRNA
responses to dietary manipulations are characterized. Additionally, in
mice the impact of knock out or of ectopic expression of pancreatic
lipase on dietary regulated expression of pancreatic lipases and
cholesterol esterase is characterized.
(4th Core Area). We will provide support services for histopathological
studies, immunohistochemical studies, and in situ hybridization studies
of tissues.
(5th Core Area). We will maintain and distribute bacterial cultures and
plasmid stocks in this Core.
这个核心实验室将在五个方面提供支持:(1)生产;
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORMAN A GRANHOLM其他文献
NORMAN A GRANHOLM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORMAN A GRANHOLM', 18)}}的其他基金
Apoj/Clusterin:A Protective Protein In Vascular Biology
Apoj/Clusterin:血管生物学中的保护蛋白
- 批准号:
6545619 - 财政年份:2002
- 资助金额:
$ 16.43万 - 项目类别:
Apoj/Clusterin:A Protective Protein In Vascular Biology
Apoj/Clusterin:血管生物学中的保护蛋白
- 批准号:
6615795 - 财政年份:2002
- 资助金额:
$ 16.43万 - 项目类别:
Apoj/Clusterin:A Protective Protein In Vascular Biology
Apoj/Clusterin:血管生物学中的保护蛋白
- 批准号:
6776944 - 财政年份:2002
- 资助金额:
$ 16.43万 - 项目类别:
CORE--IMMUNOLOGY AND MOLECULAR BIOLOGY FACILITY
核心——免疫学和分子生物学设施
- 批准号:
6578772 - 财政年份:2002
- 资助金额:
$ 16.43万 - 项目类别:
Apoj/Clusterin:A Protective Protein In Vascular Biology
Apoj/Clusterin:血管生物学中的保护蛋白
- 批准号:
6923640 - 财政年份:2002
- 资助金额:
$ 16.43万 - 项目类别:
CORE--IMMUNOLOGY AND MOLECULAR BIOLOGY FACILITY
核心——免疫学和分子生物学设施
- 批准号:
6451087 - 财政年份:2001
- 资助金额:
$ 16.43万 - 项目类别:
CORE--IMMUNOLOGY AND MOLECULAR BIOLOGY FACILITY
核心——免疫学和分子生物学设施
- 批准号:
6105874 - 财政年份:1999
- 资助金额:
$ 16.43万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 16.43万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 16.43万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 16.43万 - 项目类别:
Grant-in-Aid for Scientific Research (B)